Dare Bioscience, Inc. (DARE) vs MARKER THERAPEUTICS, INC. (MRKR)
- Dare Bioscience, Inc. DARE 0.72 −2.70%
- MARKER THERAPEUTICS, INC. MRKR 1.04 +13.04%
Dare Bioscience, Inc. and MARKER THERAPEUTICS, INC. are both Biotechnology companies. Dare Bioscience, Inc. and MARKER THERAPEUTICS, INC. are of similar size ($15.3M and $14.6M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −27.8%. MARKER THERAPEUTICS, INC. has the higher net margin (0.00% vs −804.3%) and the lower return on invested capital (−566.8% vs 0.00%). Across the 17 metrics below, MARKER THERAPEUTICS, INC. leads on 11 and Dare Bioscience, Inc. on 6.
Valuation
Profitability
| Metric | DARE | MRKR | Biotechnology median |
|---|---|---|---|
| Gross margin | 58.84% | 100.00% | 65.16% |
| Operating margin | (813.35%) | 0.00% | 0.00% |
| Net margin | (804.33%) | 0.00% | 0.00% |
| Free cash flow margin | (849.36%) | 0.00% | 0.00% |
| Return on equity | 165.29% | (76.87%) | (56.36%) |
| Return on assets | (62.16%) | (59.33%) | (48.04%) |
| Return on invested capital | 0.00% | (566.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack